1.
Defective proviruses rapidly accumulate during acute HIV-1 infection
by Bruner, Katherine M
Nature medicine, 2016-09, Vol.22 (9), p.1043-1049
2.
Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2015 : the Global Burden of Disease Study 2015
by GBD 2015 HIV Collaborators
The Lancet (British edition), 2016-08, Vol.3 (8), p.361
3.
Defining total-body AIDS-virus burden with implications for curative strategies
by Estes, Jacob D
Nature medicine, 2017-11, Vol.23 (11), p.1271-1276
4.
Evaluation of the association between the concentrations of key vaginal bacteria and the increased risk of HIV acquisition in African women from five cohorts: a nested case-control...
by McClelland, R Scott
The Lancet infectious diseases, 2018-05, Vol.18 (5), p.554-564
5.
Leishmaniasis chemotherapy—challenges and opportunities
by Croft, S.L
Clinical microbiology and infection, 2011-10, Vol.17 (10), p.1478-1483
6.
Broadly neutralizing anti-HIV-1 monoclonal antibodies in the clinic
by Caskey, Marina
Nature medicine, 2019-04, Vol.25 (4), p.547-553
7.
Technologies for global health
by Howitt, Peter, MA
The Lancet (British edition), 2012, Vol.380 (9840), p.507-535
8.
Determinants of HIV-1 transmission in men who have sex with men: a combined clinical, epidemiological and phylogenetic approach
by FISHER, Martin
AIDS (London), 2010, Vol.24 (11), p.1739-1747
9.
Social capital and HIV Competent Communities: The role of community groups in managing HIV/AIDS in rural Zimbabwe
by Campbell, Catherine
AIDS care, 2013-06-20, Vol.25 (sup1), p.S114-S122
10.
Task shifting of antiretroviral treatment from doctors to primary-care nurses in South Africa (STRETCH): a pragmatic, parallel, cluster-randomised trial
by Fairall, Lara, PhD
The Lancet (British edition), 2012, Vol.380 (9845), p.889-898
11.
Antiretroviral treatment of HIV-1 prevents transmission of HIV-1: where do we go from here?
by Cohen, Myron S, Prof
The Lancet (British edition), 2013, Vol.382 (9903), p.1515-1524
12.
Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study
by Montaner, Julio SG, Prof
The Lancet (British edition), 2010, Vol.376 (9740), p.532-539
13.
HIV and tuberculosis in prisons in sub-Saharan Africa
by Telisinghe, Lilanganee, Dr
The Lancet (British edition), 2016, Vol.388 (10050), p.1215-1227
14.
Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees
by Dolan, Kate, Prof
The Lancet (British edition), 2016, Vol.388 (10049), p.1089-1102
15.
Global epidemiology of HIV among female sex workers: influence of structural determinants
by Shannon, Kate, Dr
The Lancet (British edition), 2015, Vol.385 (9962), p.55-71
16.
HIV-hepatitis B virus coinfection: epidemiology, pathogenesis, and treatment
by Singh, Kasha P
AIDS (London), 2017-09-24, Vol.31 (15), p.2035-2052
17.
Trichomoniasis and HIV interactions: a review
by Kissinger, Patricia
Sexually Transmitted Infections, 2013-09, Vol.89 (6), p.426-433
18.
Fungal infections in HIV/AIDS
by Limper, Andrew H
The Lancet infectious diseases, 2017-11, Vol.17 (11), p.e334-e343
19.
Evolution of an HIV glycan-dependent broadly neutralizing antibody epitope through immune escape
by Moore, Penny L
Nature medicine, 2012-11, Vol.18 (11), p.1688-1692
20.
Psychiatric symptoms and antiretroviral nonadherence in US youth with perinatal HIV: a longitudinal study
by Kacanek, Deborah
AIDS (London), 2015-06-19, Vol.29 (10), p.1227-1237
